No headlines found.
Globe Newswire (Tue, 14-Jan 8:00 AM ET)
Atlantic International Corp formerly SeqLL Inc is a technology company providing life sciences instrumentation and research services in collaborative partnerships aimed at the development of novel scientific assets and intellectual property across multiple omics fields. The company leverages its expertise with the True Single Molecule Sequencing platform to empower scientists and researchers with improved genetic tools to greater understand the molecular mechanisms of disease that is essential to the continued development of new breakthroughs in genomic medicine, and that hopefully address the critical concerns involved with precision medicine.
Atlantic International Corp. trades on the NASDAQ stock market under the symbol ATLN.
As of January 17, 2025, ATLN stock price climbed to $5.65 with 34,514 million shares trading.
ATLN has a market cap of $283.33 million. This is considered a Small Cap stock.
ATLN support price is $4.17 and resistance is $6.03 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ATLN shares will trade within this expected range on the day.